Short Course Oncology Therapy: a study of adjuvant chemotherapy in colorectal cancer by the CACTUS and OCTO collaborative groups.
This study is investigating the efficacy of 3 months of adjuvant chemotherapy versus 6 months in terms of 3-year disease-free survival, overall survival, toxicity, cost-effectiveness and quality of life.
CACTUS; Cancer Australia; NHMRC CTC; AGITG
Patients with fully resected stage III colorectal cancer
Australian Lead Group:
Tim Iveson (international), Andrew Haydon (Australia)